A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612)
Clinical trial NCT00687401 · COMPLETED
Trial details
- NCT number
- NCT00687401
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2009-05-01
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.